17 articles
Shubh Goel, VP, Head of Immuno-Oncology and GI Tumors Franchise at AstraZeneca discusses data presented at the European Society for Medical Oncology (ES...
Roy Herbst, MD, PhD, from the Yale School of Medicine and primary investigatory of the ADAURA Phase III trial discusses the positive results that show T...
Anas Younes, Senior Vice President, Head of Haematology R&D, at AstraZeneca, discusses building a broad portfolio to target different hematological canc...
Shankar Musunuri, Chairman, Co-founder, and CEO of Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel g...
Angela Mickalide, PhD, MCHES, Vice President, Programs & Education, American College of Preventive Medicine discusses her involvement in the Vaccine Con...
Harlan Robins, Chief Scientific Officer and co-founder of Adaptive Biotechnologies discusses why vaccine sponsors need to rethink vaccine design to take...
Returning guest, Dr. Brian Koffman, Executive Vice President and Chief Medical Officer, CLL (chronic lymphocytic leukemia) Society, and a CLL patient di
Nora Colburn, MD, MPH, an infectious disease expert and Clinical Assistant Professor at The Ohio State University Wexner Medical Center discusses the la...
Gregg Sylvester, Chief Medical Officer at Seqirus, a global leader in influenza prevention, discusses data from a first-of-its-kind co-administration st...
Joan Merrill, MD, Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Research Program, US, discusses new Phase 3 data presented durin...